Clinical Trials Update: March 16, 2007

COPD (Chronic Obstructive Pulmonary Disease) or Emphysema Human Papillomavirus (HPV) Diabetes - Type 2

By HealthDay News HealthDay Reporter

Updated on June 12, 2022

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

COPD (Chronic Obstructive Pulmonary Disease) or Emphysema

This study will evaluate an investigational device for people with COPD. Eligible participants must be 40 or older and be current or former smokers. The study consists of six clinic visits over approximately 15-18 weeks.

The research site is in St. Louis, Mo.

More information

Please see http://www.centerwatch.com/patient/studies/cat44.html.

-----

Human Papillomavirus (HPV)

Have you been told that you have cervical HPV (human papillomavirus)? If so, you may qualify for a study to evaluate a drug that may speed healing of cervical HPV infection. This drug is applied intravaginally in the form of a gel. Women 18-40 may be eligible who have a uterine cervical sample that is HR HPV positive, have not received an active HPV vaccine at any time prior to the screening visit, and do not have evidence of genital, peri-anal or vaginal warts.

The research site is in Nashville, Tenn.

More information

Please see http://www.centerwatch.com/patient/studies/cat421.html.

-----

Diabetes - Type 2

This trial will evaluate the effectiveness and safety of an investigational medication for adults with type 2 diabetes. Volunteers 18-80 who have been on a stable dose of metformin of at least 1,000 mg/day for at least the prior four weeks may be included.

The research site is in Gainesville, Fla.

More information

Please see http://www.centerwatch.com/patient/studies/cat603.html.

-----

Copyright 2007 Thomson CenterWatch. All rights reserved.

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ